What we do

Xpan is developing novel minimally invasive surgical access instruments (trocars/ports) that aim to:

Increase Patient Safety

Increase Surgical Efficiency

Reduce Hospital Costs

FIND US IN THE NEWS

OICR-FACIT Interview Facit Falcon’s Fortunes win & Oncology Investment press release 2019  Synapse Life Science competition 2019     Xpan is selected as 1 of 15 Canadian Life Science startups to participate in Dose of the Valley event which is organized by the Canadian Consulate in San Francisco. Feb 2019     UofT RBC Challenge Early Stage Competition 2018Hatchery demo day win 2017   H2i Pitch Perfect win 2017   Health Edge Competition 2018 Follow up interview from Pitch Perfect 2017                           Xpan participates in the SCI Innovation competition and roadshow in Shenzhen, China: April 2019 Xpan attends the 63rd ASAIO (American Society for Artificial Internal Organs) conference in Chicago and places 2nd in the Student Design Competition for young innovators

Minimally Invasive Surgery by the Numbers

Xpan’s products target:

15 MM +
Surgeries / Year Globally
5 MM +
Surgeries / Year in US Alone
1.3 B +
Single Use Port Global Market Size

Contact us



Address

100 College St. Suite 150, Toronto, ON